Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma
Clinical trial NCT03829969 · COMPLETED
Trial details
- NCT number
- NCT03829969
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-31
- Primary completion
- 2021-03-22
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.